chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Inappropriate schedule of product administration, Lethargy, Myalgia, Nasal congestion
Clinical narrative: Sore throat; congested; 2nd dose - lethargic for 24 hours.; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231, expiration date 30Apr2021), via an unspecified route of administration on right arm at 08:30 AM on 06Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroid. Concomitant medication included levothyroxine, vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D) and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 at single dose for COVID-19 immunization and experienced minimal pain right deltoid area. For the second dose, the patient experienced lethargic for 24 hours, intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm). Took Tylenol to decrease muscle and joint pain, which helped. Day 4 post vaccine on 10Jan2021, slight sore throat, congested, but muscle and joint pain generally resolved. It was only day 4. The outcome of events muscle pain and joint pain was recovered on 10Jan2021, the outcome of reset events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the had not patient been tested for COVID-19.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Sore throat; congested; 2nd dose - lethargic for 24 hours.; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231, expiration date 30Apr2021), via an unspecified route of administration on right arm at 08:30 AM on 06Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroid. Concomitant medication included levothyroxine, vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D) and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 at single dose for COVID-19 immunization and experienced minimal pain right deltoid area. For the second dose, the patient experienced lethargic for 24 hours, intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm). Took Tylenol to decrease muscle and joint pain, which helped. Day 4 post vaccine on 10Jan2021, slight sore throat, congested, but muscle and joint pain generally resolved. It was only day 4. The outcome of events muscle pain and joint pain was recovered on 10Jan2021, the outcome of reset events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the had not patient been tested for COVID-19.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pelvic pain, Pyrexia
Clinical narrative: fever; chills/Shivering; pelvic pain; nausea; headache; This is a spontaneous report from a contactable consumer.  A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on the left arm on 06Jan2021 15:15 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history was reported as none.  Concomitant medications were not reported. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot/batch number: not provided) via unknown route of administration on the left arm on 20Dec2020 16:15 at a single dose for COVID-19 immunization. On 07Jan2021 04:00, the patient had fever, chills/shivering, pelvic pain, headache, and nausea symptoms resolved next day (08Jan2021). Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The patient did not receive any treatment for the events.    Information about lot/batch number has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, SARS-CoV-2 test
Clinical narrative: Change is related to sense of smell.  Sweet aromas are not the same, the perception of sweeter aromas is altered.; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) solution for injection, via an unspecified route of administration on left arm on 28Dec2020 12:30 at a single dose for COVID-19 immunization. The patient medical history included allergy to echinacea. The patient was not pregnant. Concomitant medications included vitamin b complex and glucosamine. The patient reported that a change was related to sense of smell. Sweet aromas were not the same, the perception of sweeter aromas was altered on 31Dec2020. No treatment was received. The patient underwent nasal swab and tested negative on 06Jan2021. Outcome of the event was not recovered.  No follow-up activities are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Myalgia; Chills; Nausea; Joint pain; Headache; Fatigue; This is a spontaneous report from a non-contactable pharmacist (patient herself). A 29-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the right arm on 06Jan2021 18:15 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient previously took first dose of bnt162b2 (lot number: EL0140, expiry date not reported) in the right arm on 18Dec2020 at single dose for COVID-19 immunisation. On 07Jan2021 at 02:00, the patient experienced myalgia, chills, nausea, joint pain, headache and fatigue. No therapeutic measure was taken as a result of the events. Clinical outcome of the events was recovered on 08Jan2021 at 02:00.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Myalgia; Chills; Nausea; Joint pain; Headache; Fatigue; This is a spontaneous report from a non-contactable pharmacist (patient herself). A 29-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the right arm on 06Jan2021 18:15 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient previously took first dose of bnt162b2 (lot number: EL0140, expiry date not reported) in the right arm on 18Dec2020 at single dose for COVID-19 immunisation. On 07Jan2021 at 02:00, the patient experienced myalgia, chills, nausea, joint pain, headache and fatigue. No therapeutic measure was taken as a result of the events. Clinical outcome of the events was recovered on 08Jan2021 at 02:00.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: fever; chills; muscle aches; This is a spontaneous report form a contactable other healthcare professional (Other HCP) reporting for herself. A 22-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EK9231, expiry date: not reported) via an unspecified route of administration, on 07Jan2021 on Arm Left at a single dose for COVID-19 immunization. COVID-19 vaccine was administered at a hospital. Medical history was not reported. The patient has no known allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had undergone Nasal Swab tests on 08Nov2020 and 05Dec2020, both with negative results. Concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EK5730, expiry date: not reported) via an unspecified route of administration, on 17Dec2020 03:30 PM on Arm Right at a single dose for COVID-19 immunization (at the age of 22-year-old). On 08Jan2021 02:45 AM, the patient had a fever, chills and muscle aches in the middle of the night into the morning of the following day. Treatment was not received for the adverse events. Outcome of the events was recovering.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Pain
Clinical narrative: headache; terrible body aches; feels so bad; This is a spontaneous report from a contactable consumer. A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date unknown, via an unspecified route of administration on 19Dec2020 at a SINGLE DOSE then via an unspecified route of administration on 07Jan2021 at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 07Jan2021, the patient took the second vaccine and feels so bad (headache, terrible body aches) and had to go home from work. The outcome of the event was unknown.   Information about Lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Nausea, SARS-CoV-2 test
Clinical narrative: About 1 hr after vaccination, started to feel nauseous and bad headache, increased over 3 hr, felt "brain fuzzy" after  1 hr.; About 1 hr after vaccination, started to feel nauseous and bad headache, increased over 3 hr, felt "brain fuzzy" after  1 hr.; About 1 hr after vaccination, started to feel nauseous and bad headache, increased over 3 hr, felt "brain fuzzy" after  1 hr.; This is a spontaneous report from a contactable consumer. A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176; expiry date: unknown) via an unspecified route of administration (left arm), on 08Jan2021 at 12:30, at a single dose, for COVID-19 immunization. Relevant medical history included atopic dermatitis, allergy to latex, nitrile, nickel, mint, mango, eggplant, tomatoes, coconut, some specific blue pigments. Concomitant medications included dupilumab (DUPIXENT), fluoxetine (FLUOXETINE), ibuprofen (IBUPROFEN), and vitamin D3). The patient previously received dexamethasone and experienced allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) in the left arm, on 18Dec2020 at 12:00, for COVID-19 immunization. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 21Dec2020, the patient showed a negative nasal swab. On 08Jan2021, at 13:30, about 1 hour after vaccination, patient started to feel nauseous, experienced bad headache which increased over 3 hours, and felt "brain fuzzy" after 1 hour. Three hours after onset, patient took Tylenol 1000 mg and Dramamine as treatment for the events. Outcome of the events was recovering. The patient underwent PCR test post vaccination with an unknown result.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Nausea, Pain in extremity, Vaccination site warmth
Clinical narrative: Hot injection site; sore arm; swollen  lip; nausea; This is a spontaneous report from a contactable other healthcare professional (HCP). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 08Jan2021 07:00 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history reported as none. The patient's concomitant medications were not reported. The patient's historic vaccine included Other Pfizer vaccine on 18Dec2020. The patient experienced hot injection site, sore arm, swollen lip, nausea on 09Jan2021 15:00. Therapeutic measures were taken as a result of events included Benadryl. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering. Information on Lot/ Batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Lymph node - just above left mid-subclavian (vaccination was administered in left upper arm); This is a spontaneous report from a contactable Other HCP. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL1283, via an unspecified route of administration on left arm on 06Jan2021 17:30 at a SINGLE DOSE and (lot number:EK5730), via an unspecified route of administration on left arm on 16Dec2020 19:15 at a SINGLE DOSE for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing.  Concomitant medication included colecalciferol (VITAMIN D [COLECALCIFEROL]), hydrochlorothiazide, valsartan (VALSARTAN & HCTZ). The patient experienced swollen lymph node - just above left mid-subclavian (vaccination was administered in left upper arm) on 07Jan2021 09:00 with outcome of not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Nausea
Clinical narrative: Muscle aches; Dizziness; Nausea; This is a spontaneous report from a non-contactable healthcare professional (patient). A 25-year-old female patient (non-pregnant) received the first and second doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in left arm, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a military base. On 02Jan2021, the patient experienced muscle aches, dizziness, and nausea. No treatment was received for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The patient was recovering from the events.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Rash on chest and back - light red, mildly itchy; This is a spontaneous report from a contactable other health care professional. A 43-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EJ1685), intramuscular on 06Jan2021 at single dose at arm right for COVID-19 immunization. Medical history included Multiple Sclerosis, hypertension, depression/anxiety, chronic sinusitis. Concomitant medications included dimethyl fumarate (TECFIDERA), gabapentin, buspirone hydrochloride (BUSPAR), fluoxetine hydrochloride (PROZAC), losartan, fexofenadine hydrochloride (ALLEGRA), and montelukast sodium (SINGULAIR). The patient previously took benazepril and has Known allergies: Benazepril. On 08Jan2021, the patient experienced Rash on chest and back - light red, mildly itchy.  The events were assessed as non-serious. The patient did not receive treatment for the adverse event. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the event was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer via a sales representative. A male patient of an unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date not reported), via an unspecified route of administration from an unspecified date at a single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for Covid-19 immunization. On an unspecified date, the patient experienced just a headache, occurred after the patient received the second injection in the series. Outcome of the event was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever to 99.8; muscle aches; Headache; sore arm for days; This is a spontaneous report from a non-contactable nurse. A 40-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 28Dec2020 12:00 to 28Dec2020 12:00 at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported.  The patient previously took chlorhexidine and experienced allergies. The patient experienced Fever to 99.8 body, muscle aches, Headache and sore arm for days, felt like being punched repeatedly in the arm; all on 28Dec2020. The outcome of the event was recovered on unspecified dates.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Nausea, Pyrexia
Clinical narrative: fever (101.5º); chills; muscle aches; nausea; This is a spontaneous report from a contactable Nurse (patient). A 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL1284), intramuscularly on 07Jan2021 at single dose for covid-19 immunization. Vaccine location was right arm and it was the second dose. The facility type vaccine was hospital. Patient Intramuscularly received the first dose of BNT162B2 on 17Dec2020 (lot number EH9899) at arm left. Patient is not pregnant. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever (101.5º), chills, muscle aches, nausea on 08Jan2021 with outcome of recovered in Jan2021. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchiness (like something crawling in my face and extremities) all over intermittently lasted 2 days; This is a spontaneous report from a contactable nurse. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration, at the left arm on 23Dec2020 09:30 at single dose for COVID-19 immunization at a hospital.  Medical history included dry eyes, carcinoma in situ, and procedure of complete hysterectomy. The patient was not pregnant at the time of vaccination. Concomitant medications included camellia sinensis extract (GREEN TEA), ciclosporin (RESTASIS), estradiol (VIVELLE DOT). The patient previously took augmentin and experienced allergies.  The patient experienced itchiness (like something crawling in my face and extremities) all over intermittently lasted 2 days on 23Dec2020 09:30 and was treated with cetirizine hydrochloride (ZYRTEC)  x1 on the second day. The patient recovered from  the event on 25Dec2020.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase, Blood pressure measurement, Chills, Gamma-glutamyltransferase, Heart rate
Clinical narrative: shivering; tachycardia; BP 139/89/BP 148/91; Left arm very sore; Left arm tingled; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 53-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 10:30 in left arm at single dose for COVID-19 immunization. Medical history included mild hypertension, chronic migraine and recent elevated liver tests - Alk Phos (alkaline phosphatase) & GGT (Gamma-glutamyltransferase) from an unknown date and unknown if ongoing. Concomitant medication included metoprolol succinate 25 mgs daily and colecalciferol (VITAMIN D). On 07Jan2021 21:30, following shot for a few minutes, the patient experienced left arm tingled, had a brief period lasting a few minutes of shivering that evening and tachycardia. Noted at 9:30 pm, patient's BP 139/89, pulse 88 (BP 115/88 and pulse 76 4 days prior). Then BP 148/91, pulse 69 at 10 am on 08Jan2021 after two doses of Metoprolol Succinate ER 25 mgs at 9:45 pm on 07Jan2021 and at 8:30 am on 08Jan2021. The patient experienced left arm very sore on 07Jan2021 after receiving vaccine. Seems to be improving on 08Jan2021. The outcome of the events was not recovered. no treatment was given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Pain in extremity, Paraesthesia, Tachycardia
Clinical narrative: shivering; tachycardia; BP 139/89/BP 148/91; Left arm very sore; Left arm tingled; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 53-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 10:30 in left arm at single dose for COVID-19 immunization. Medical history included mild hypertension, chronic migraine and recent elevated liver tests - Alk Phos (alkaline phosphatase) & GGT (Gamma-glutamyltransferase) from an unknown date and unknown if ongoing. Concomitant medication included metoprolol succinate 25 mgs daily and colecalciferol (VITAMIN D). On 07Jan2021 21:30, following shot for a few minutes, the patient experienced left arm tingled, had a brief period lasting a few minutes of shivering that evening and tachycardia. Noted at 9:30 pm, patient's BP 139/89, pulse 88 (BP 115/88 and pulse 76 4 days prior). Then BP 148/91, pulse 69 at 10 am on 08Jan2021 after two doses of Metoprolol Succinate ER 25 mgs at 9:45 pm on 07Jan2021 and at 8:30 am on 08Jan2021. The patient experienced left arm very sore on 07Jan2021 after receiving vaccine. Seems to be improving on 08Jan2021. The outcome of the events was not recovered. no treatment was given to the patient for the events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dry mouth, Fatigue, Headache, Pyrexia
Clinical narrative: Fatigue; Dry mouth; Low grade fever; Chills; Headache; Itchy rash at injection site; Itchy rash at injection site; Soreness at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 31Dec2020 12:45 at left arm, at single dose for covid-19 immunization. Medical history known allergies: penicillin, chocolate from an unknown date. Concomitant medication included acetylsalicylic acid (ASPIRIN) and Birth control pills. The patient previously took erythromycin and known allergies: Erythromycin. The patient was not pregnant at the time of vaccination. The patient experienced fatigue, dry mouth, low grade fever, chills, headache, itchy rash at injection site, soreness at injection site on 31Dec2020 15:00. No treatment was received for all events. The outcome of the events was recovered on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.  No follow up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Fatigue; Dry mouth; Low grade fever; Chills; Headache; Itchy rash at injection site; Itchy rash at injection site; Soreness at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 31Dec2020 12:45 at left arm, at single dose for covid-19 immunization. Medical history known allergies: penicillin, chocolate from an unknown date. Concomitant medication included acetylsalicylic acid (ASPIRIN) and Birth control pills. The patient previously took erythromycin and known allergies: Erythromycin. The patient was not pregnant at the time of vaccination. The patient experienced fatigue, dry mouth, low grade fever, chills, headache, itchy rash at injection site, soreness at injection site on 31Dec2020 15:00. No treatment was received for all events. The outcome of the events was recovered on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.  No follow up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: low grade fever, 99 degrees Fahrenheit starting the day following injection, lasting 1 day; Fatigue, moderate, lasting 1 day; Headache, moderate, lasting 1 day; This is a spontaneous report from a contactable consumer. A 26-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown) at the hospital, via an unspecified route of administration on 28Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. On 28Dec2020, the patient experienced fatigue, moderate, lasting 1 day, headache, moderate, lasting 1 day, and low grade fever, 99 degrees Fahrenheit starting the day following injection, lasting 1 day. The events were considered as non-serious. No treatment was received for the events. It was unknown if patient was diagnosed with COVID-19 prior to vaccination. It was also unknown if patient has been tested for COVID-19 since the vaccination. The events recovered on 29Dec2020.  Information about batch/lot number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; body aches; fatigue; This is a spontaneous report from a contactable nurse. A 48-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 22Dec2020 11:30 to 22Dec2020 11:30 at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. The patient previously took aspirin, erythromycin, vancomycin and cipro; all experienced allergies. The patient had fever, body aches and fatigue on 01Jan2021. The outcome of the events was recovered in Jan2021.  Information on the lot/batch number has been requested.
Age: 31.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Lethargy, Malaise, Myalgia, Vaccination site pain
Clinical narrative: Muscle aches; joint aches; lethargy; soreness at injection site; under the weather; This is a spontaneous report from a contactable other healthcare professional (patient). A 31-year-old patient of unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date unknown), via an unspecified route of administration on 08Jan2021 at 19:30 on Arm left at single dose for COVID-19 immunization. Medical history included Hypertension. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications included Fluoxetine, Amlodipine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took venlafaxine and experienced allergy. The patient experienced Muscle aches, joint aches, lethargy, soreness at injection site, under the weather on 09Jan2021 at 19:30. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Feeling hot, Muscular weakness, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: the skin overlying the injection site has an intense prickly "itchy" sensation; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; I had a short episode of disequilibrium; awoken by intense bilateral leg pain; my legs felt weak the following day; This is a spontaneous report from a contactable Physician who reported for herself.  A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EK9231)  for COVID-19 immunisation on 07Jan2021 at 15:30 at single dose in Left arm. Medical history included allergy to penicillin , clindamycin, azathioprine (IMURAN) (known allergies: penicillin, clindamycin, Imuran) , allergy to glove powder and autoimmune disorder (unspecified). Concomitant medication (received within 2 weeks of vaccination) included hydroxychloroquine sulfate (PLAQUENIL), methotrexate, mycophenolate mofetil (CELLCEPT), folic acid and magnesium. On 07Jan2021 at 17:30 , approximately 2 hours after she received the vaccine, she had a short episode of disequilibrium, then an hour after that (at 18.30) the left side of her face felt heavy, stiff and was palpably warmer than the right side of her face. There were no visible changes to the appearance of her face, and she had normal motor control. This episode lasted for approximately 1-2 hours then gradually diminished. In Jan202, approximately 36 hours after the vaccine, patient was awoken by intense bilateral leg pain. The pain gradually diminished after approximately an hour, but her legs felt weak the following day. Legs were fine on 10Jan2021. In the evening of 09Jan2021 though 10Jan2021, the skin overlying the injection site had an intense prickly "itchy" sensation, there was no rash. Events were all non serious. No treatment administered and final outcome for all the events was reported as recovering.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: the skin overlying the injection site has an intense prickly "itchy" sensation; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; left side of my face felt heavy, stiff, and was palpably warmer than the right side of my face; I had a short episode of disequilibrium; awoken by intense bilateral leg pain; my legs felt weak the following day; This is a spontaneous report from a contactable Physician who reported for herself.  A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EK9231)  for COVID-19 immunisation on 07Jan2021 at 15:30 at single dose in Left arm. Medical history included allergy to penicillin , clindamycin, azathioprine (IMURAN) (known allergies: penicillin, clindamycin, Imuran) , allergy to glove powder and autoimmune disorder (unspecified). Concomitant medication (received within 2 weeks of vaccination) included hydroxychloroquine sulfate (PLAQUENIL), methotrexate, mycophenolate mofetil (CELLCEPT), folic acid and magnesium. On 07Jan2021 at 17:30 , approximately 2 hours after she received the vaccine, she had a short episode of disequilibrium, then an hour after that (at 18.30) the left side of her face felt heavy, stiff and was palpably warmer than the right side of her face. There were no visible changes to the appearance of her face, and she had normal motor control. This episode lasted for approximately 1-2 hours then gradually diminished. In Jan202, approximately 36 hours after the vaccine, patient was awoken by intense bilateral leg pain. The pain gradually diminished after approximately an hour, but her legs felt weak the following day. Legs were fine on 10Jan2021. In the evening of 09Jan2021 though 10Jan2021, the skin overlying the injection site had an intense prickly "itchy" sensation, there was no rash. Events were all non serious. No treatment administered and final outcome for all the events was reported as recovering.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Heart rate, Heart rate increased, Nausea
Clinical narrative: Nausea; fast heart rate; low grade temp (99.4-100); headache; body aches; soreness at site; This is a spontaneous report from a contactable Nurse (patient herself). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 13:00 (Lot number: EK5730) at SINGLE DOSE (first dose, left arm); and via an unspecified route of administration on 07Jan2021 13:00 (Lot number: EK9231) at SINGLE DOSE (second dose, left arm) for COVID-19 immunization. Medical history included hypertension, high cholesterol, Graves disease, and Known allergies: Sulfa from an unknown date and unknown if ongoing.  The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 since vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the vaccine at hospital. Concomitant medication included hydrochlorothiazide, atorvastatin, amlodipine from unspecified dates for unspecified indications. The patient experienced nausea, fast heart rate, low grade temp (99.4-100), headache, body aches, soreness at site on 08Jan2021 06:00. The patient underwent lab tests and procedures which included temp 99.4-100 and heart rate fast on 08Jan2021. Treatment was not received for adverse events. Event outcome was recovering. The reporter assessed the events as non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site pain
Clinical narrative: Nausea; fast heart rate; low grade temp (99.4-100); headache; body aches; soreness at site; This is a spontaneous report from a contactable Nurse (patient herself). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 13:00 (Lot number: EK5730) at SINGLE DOSE (first dose, left arm); and via an unspecified route of administration on 07Jan2021 13:00 (Lot number: EK9231) at SINGLE DOSE (second dose, left arm) for COVID-19 immunization. Medical history included hypertension, high cholesterol, Graves disease, and Known allergies: Sulfa from an unknown date and unknown if ongoing.  The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 since vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the vaccine at hospital. Concomitant medication included hydrochlorothiazide, atorvastatin, amlodipine from unspecified dates for unspecified indications. The patient experienced nausea, fast heart rate, low grade temp (99.4-100), headache, body aches, soreness at site on 08Jan2021 06:00. The patient underwent lab tests and procedures which included temp 99.4-100 and heart rate fast on 08Jan2021. Treatment was not received for adverse events. Event outcome was recovering. The reporter assessed the events as non-serious.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Vomiting
Clinical narrative: nausea; vomiting; chills; headache; This is a spontaneous report from a non-contactable nurse (patient). A 55-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EL1283), via an unspecified route of administration on 07Jan2021 at 10:30 AM on the left arm at a single dose for COVID-19 immunization.  Medical history included allergies to sulfa. The patient's concomitant medications were not reported. The patient previously received the first dose of (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EJ1685) on 21Dec2020 at 10:00 AM on the left arm for COVID-19 immunization. The vaccine was administered in the hospital. The patient was not administered any other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The patient experienced nausea, vomiting, chills and headache on 07Jan2021 at 11:45 PM. The patient did not receive treatment for the events. The outcome of the events was recovering. The events were reported to be non-serious.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache
Clinical narrative: bad headache; dizzy; weak; tired; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient who is a doctor had a bad headache, was dizzy, weak and tired after receiving the vaccine on an unknown date in Jan2021 with outcome of unknown.   Information about lot/batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Tinnitus
Clinical narrative: funky lightheadedness; weird feelings in head; tinnitus was noticeably oscillated up and down; This is a spontaneous report from a contactable pharmacist. A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FK4176), intramuscularly on 07Jan2021 at 13:30 at a single dose on the left arm for COVID-19 immunization. Medical history was reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and was not diagnosed with COVID-19 prior to vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), intramuscularly on 17Dec2020 at 13:30 on the right arm for COVID-19 immunization and experienced funky lightheadedness, vertigo, normal tinnitus got louder and oscillating up and down, and sinus headache. Concomitant medication included colecalciferol (VITAMIN D). On 07Jan2021 at 13:30 (as reported), patient experienced funky lightheadedness, weird feelings in head, and tinnitus was noticeably oscillated up and down. The events were assessed as non-serious. The patient did not receive any treatment for the events. The patient was not pregnant at the time of vaccination. The outcome of the events was recovered on 07Jan2021 at 15:30.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear pain, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Headache; body ache; nausea; fatigue; ear pain; sweating; dizziness; This is a spontaneous report from a contactable other HCP (patient). A 41-year-old female patient (no pregnant) received first dose of BNT162B2 (Lot number= Ek5730) Intramuscular on 23Dec2020 00:30 AM (reported as 22Dec2020 12:30 PM) at single dose on Left arm for COVID-19 immunization. Medical history was Idiopathic Angiodema (Allergies). Concomitant drug included Levonorgestrel and ethinyl estradiol in two weeks. Adverse event reported as Headache, body ache, nausea, fatigue, ear pain x 2 days, sweating, dizziness (all non-serious) on 23Dec2020 09:00 AM. No treatment. No Covid prior vaccination. No covid tested post vaccination. NO any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not been tested for COVID-19. Outcome of the event of ear pain was recovered on 25Dec2020, for other events was recovered.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Headache; body ache; nausea; fatigue; ear pain; sweating; dizziness; This is a spontaneous report from a contactable other HCP (patient). A 41-year-old female patient (no pregnant) received first dose of BNT162B2 (Lot number= Ek5730) Intramuscular on 23Dec2020 00:30 AM (reported as 22Dec2020 12:30 PM) at single dose on Left arm for COVID-19 immunization. Medical history was Idiopathic Angiodema (Allergies). Concomitant drug included Levonorgestrel and ethinyl estradiol in two weeks. Adverse event reported as Headache, body ache, nausea, fatigue, ear pain x 2 days, sweating, dizziness (all non-serious) on 23Dec2020 09:00 AM. No treatment. No Covid prior vaccination. No covid tested post vaccination. NO any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient was not been tested for COVID-19. Outcome of the event of ear pain was recovered on 25Dec2020, for other events was recovered.  No follow-up attempts possible. No further information expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Pyrexia
Clinical narrative: Headache; Chills; Swollen lymph node; exhaustion; fever; vomiting; This is a spontaneous report from a contactable consumer reported for self. This 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on 08Jan2021 09:30 AM at single dose in right arm at nursing home/senior living facility for COVID-19 immunization. The patient is not pregnant. The patient medical history included known allergies: milk products, Crohn's disease. The patient did not have COVID prior vaccination. The patient concomitant mediations included bupropion hydrochloride (WELLBUTRIN XL), hydroxyzine. The patient did not receive vaccine in four weeks. The patient experienced headache, chills, swollen lymph node, exhaustion, fever, vomiting in Jan2021. The onset date of events was reported as "01Jan2021". The events were reported as non-serious by reporter. The patient did not test COVID post vaccination. The patient did not receive treatment. The outcome of events was not resolved.   Information about lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Chills; Swollen lymph node; exhaustion; fever; vomiting; This is a spontaneous report from a contactable consumer reported for self. This 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on 08Jan2021 09:30 AM at single dose in right arm at nursing home/senior living facility for COVID-19 immunization. The patient is not pregnant. The patient medical history included known allergies: milk products, Crohn's disease. The patient did not have COVID prior vaccination. The patient concomitant mediations included bupropion hydrochloride (WELLBUTRIN XL), hydroxyzine. The patient did not receive vaccine in four weeks. The patient experienced headache, chills, swollen lymph node, exhaustion, fever, vomiting in Jan2021. The onset date of events was reported as "01Jan2021". The events were reported as non-serious by reporter. The patient did not test COVID post vaccination. The patient did not receive treatment. The outcome of events was not resolved.   Information about lot/batch number has been requested.